About Us
About Us
Aizen is an AI-driven biotechnology company pioneering Mirror Peptides, a novel class of biologic medicines. Mirror Peptides are synthetic, fully D-amino acid peptides that represent a vast, unexplored therapeutic chemical space that provide enhanced therapeutic stability and reduced exogenous immunogenicity for patients.
Aizen discovers these Mirror Peptides through a proprietary, AI protein design platform developed by Caltech Professor David Van Valen, MD. Backed by life science venture capital and based in the biotech hub of San Diego, CA, Aizen is advancing a diverse portfolio of therapeutics for diseases in neurological disorders, solid tumor cancers, and genetic diseases.

David Van Valen MD, PhD
Scientific founder
Leadership Team

Ajay Kshatriya
CEO and Co-founder

Dillon Phan
VP Drug Discovery

Luke Ursell
VP Business Development
Scientific Advisory Board

Todd Peterson
Chairman and Co-founder

Michael Kay
Member

Anil Bagri
Member

Lab and Office in San Diego, CA
9276 Scranton Rd, Suite 500San Diego, CA 92121
Email us at info@aizentx.com